Cerulean Pharma reported $16.05M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Adamis Pharmaceuticals ADMP:US 13.58M 2.36M
Agile Therapeutics AGRX:US $ 25.85M 3.43M
Arrowhead Research ARWR:US $ 138.86M 1.82M
Bayer BAYN:GR € 31019M 1616M
Biocept BIOC:US $ 14.1M 2.32M
Brainstorm Cell Therapeutics BCLI:US $ 7.37M 1.06M
Cerulean Pharma CERU:US $ 16.05M 0.15M
Immunogen IMGN:US $ 84.12M 16.83M
Merk MRK:US $ 22316M 1556M
Nektar Therapeutics NKTR:US $ 85.2M 54.77M
Perrigo Ordinary Shares PRGO:US $ 981.3M 606.6M
Seattle Genetics SGEN:US $ 531.29M 37.56M
YTE INCY:US $ 886.16M 31.86M